BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23872308)

  • 1. Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Thiago LS; Perez-Andres M; Balanzategui A; Sarasquete ME; Paiva B; Jara-Acevedo M; Barcena P; Sanchez ML; Almeida J; González M; San Miguel JF; Garcia-Sanz R; Orfao A
    Haematologica; 2014 Jan; 99(1):155-62. PubMed ID: 23872308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In multiple myeloma clonotypic CD38- /CD19+ / CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes.
    Rasmussen T; Lodahl M; Hancke S; Johnsen HE
    Leuk Lymphoma; 2004 Jul; 45(7):1413-7. PubMed ID: 15359642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry.
    Conway EJ; Wen J; Feng Y; Mo A; Huang WT; Keever-Taylor CA; Hari P; Vesole DH; Chang CC
    Arch Pathol Lab Med; 2009 Oct; 133(10):1594-9. PubMed ID: 19792049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction.
    Szczepek AJ; Seeberger K; Wizniak J; Mant MJ; Belch AR; Pilarski LM
    Blood; 1998 Oct; 92(8):2844-55. PubMed ID: 9763569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonally related IgA- and IgE-secreting plasma cells in a myeloma patient.
    Bakkus MH; Schots R; Gomez La Fuente PB; Van Riet I; Thielemans K; De Waele M; Van Camp B
    Eur J Haematol; 2000 Nov; 65(5):348-55. PubMed ID: 11092467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.
    Schmidt-Hieber M; Gutiérrez ML; Pérez-Andrés M; Paiva B; Rasillo A; Tabernero MD; Sayagués JM; Lopez A; Bárcena P; Sanchez ML; Gutiérrez NC; San Miguel JF; Orfao A
    Haematologica; 2013 Feb; 98(2):279-87. PubMed ID: 22929983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M
    Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain.
    Bergsagel PL; Smith AM; Szczepek A; Mant MJ; Belch AR; Pilarski LM
    Blood; 1995 Jan; 85(2):436-47. PubMed ID: 7529064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells.
    Chen BJ; Epstein J
    Blood; 1996 Mar; 87(5):1972-6. PubMed ID: 8634446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The blood B-cells and bone marrow plasma cells in patients with multiple myeloma share identical IgH rearrangements.
    Bergsagel PL; Masellis Smith A; Belch AR; Pilarski LM
    Curr Top Microbiol Immunol; 1995; 194():17-24. PubMed ID: 7534667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing of peripheral B-lineage cells pinpoints the circulating clonotypic cell pool in multiple myeloma.
    Thiele B; Kloster M; Alawi M; Indenbirken D; Trepel M; Grundhoff A; Binder M
    Blood; 2014 Jun; 123(23):3618-21. PubMed ID: 24753536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD229 Expression on Bone Marrow Plasma Cells from Patients with Multiple Myeloma and Monoclonal Gammopathies of Uncertain Significance.
    Carulli G; Buda G; Azzarà A; Ciancia EM; Sammuri P; Domenichini C; Guerri V; Petrini M
    Acta Haematol; 2016; 135(1):11-4. PubMed ID: 26303094
    [No Abstract]   [Full Text] [Related]  

  • 13. Is multidrug resistance (P-glycoprotein) an intrinsic characteristic of plasma cells in patients with monoclonal gammopathy of undetermined significance, plasmacytoma, multiple myeloma and amyloidosis?
    Mongkonsritragoon W; Kimlinger T; Ahmann G; Greipp PR
    Leuk Lymphoma; 1998 May; 29(5-6):577-84. PubMed ID: 9643571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of B-cell subpopulations in monoclonal gammopathies.
    Všianská P; Říhová L; Varmužová T; Suská R; Kryukov F; Mikulášová A; Kupská R; Penka M; Pour L; Adam Z; Hájek R
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):e61-71. PubMed ID: 25578543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Bolzoni M; Ronchetti D; Storti P; Donofrio G; Marchica V; Costa F; Agnelli L; Toscani D; Vescovini R; Todoerti K; Bonomini S; Sammarelli G; Vecchi A; Guasco D; Accardi F; Palma BD; Gamberi B; Ferrari C; Neri A; Aversa F; Giuliani N
    Haematologica; 2017 Apr; 102(4):773-784. PubMed ID: 28057743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of circulating clonal CD19+ cells in multiple myeloma.
    Rasmussen T
    Leuk Lymphoma; 2001; 42(6):1359-66. PubMed ID: 11911420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow B lymphocytes in multiple myeloma and MGUS: Focus on distribution of naïve cells and memory subsets.
    Pojero F; Casuccio A; Giambanco C; Bulati M; Buffa S; Di Bassiano F; Gervasi F; Caruso C; Colonna Romano G
    Leuk Res; 2016 Oct; 49():51-9. PubMed ID: 27552680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma.
    Rasmussen T; Haaber J; Dahl IM; Knudsen LM; Kerndrup GB; Lodahl M; Johnsen HE; Kuehl M
    Haematologica; 2010 Oct; 95(10):1730-7. PubMed ID: 20511669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance in multiple myeloma: novel therapeutic targets within the malignant clone.
    Pilarski LM; Mant MJ; Belch AR
    Leuk Lymphoma; 1999 Jan; 32(3-4):199-210. PubMed ID: 10037018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.